Clinical trial

Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer

NCT01800422

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-06-01

PhasePHASE2

Study timeline

Study start (unknown)2013-06-01Date precision: month

Registry last updated2020-01-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Stage IA Breast Cancerunresolved

Stage IB Breast Cancerunresolved

Stage II Breast Cancerunresolved

Interventions

telapristone acetateDRUG

therapeutic conventional surgeryPROCEDURE

laboratory biomarker analysisOTHER

questionnaire administrationOTHER

Sponsors & collaborators

Northwestern Universitylead sponsor

Breast Cancer Research Foundationcollaborator

Repros Therapeutics Inc.collaborator

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01800422 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.